11,172 results on '"TAKOTSUBO CARDIOMYOPATHY"'
Search Results
2. The GErman Italian Spanish Takotsubo (GEIST) Registry (GEIST)
- Author
-
University of Foggia and Prof. Dr. med. Ingo Eitel, Director
- Published
- 2024
3. Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition (CHIEFTain)
- Published
- 2024
4. Cyclosporine In Takotsubo Syndrome (CIT)
- Author
-
German Centre of Cardiovascular Research (DZHK), Coordinating Centre for Clinical Studies (KKS) Heidelberg, and Norbert Frey, MD, Professor Dr. Norbert Frey, MD
- Published
- 2024
5. Predicting the Development of Myocardial Depression in Acute Neurological Patients
- Author
-
Tamara Strohm, Assistant Professor- Neurology
- Published
- 2024
6. Registry of Patients With Takotsubo Syndrome
- Published
- 2024
7. Autonomic Modulation in Takotsubo Syndrome
- Published
- 2024
8. Effectiveness of a Resilience-Based Rehabilitation Program for Patients With Coronary Heart Disease
- Published
- 2024
9. Comparison of Free-breathing 3D Quantitative Perfusion in Patients With MINOCA and MINOCA-mimics (COPE-CMR)
- Author
-
ETH Zurich
- Published
- 2024
10. Prognotic Role of CMR in Takotsubo Syndrome (EVOLUTION)
- Author
-
Riccardo Cau, Principal investigator
- Published
- 2024
11. Characterization of priMary And sEcondary STress Related takOtsubo (MAESTRO)
- Author
-
MONTONE ROCCO ANTONIO, IRCCS Researcher
- Published
- 2024
12. Takotsubo Syndrome and Air Pollution (Tako-Air)
- Author
-
MONTONE ROCCO ANTONIO, IRCCS Researcher
- Published
- 2024
13. BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
- Author
-
Göteborg University
- Published
- 2024
14. Complex Presentation of Pheochromocytoma: Hypertensive Encephalopathy and Takotsubo-Like Cardiomyopathy in a Young Female.
- Author
-
Garg, Nidhi, Raavi, Lekhya, Maheshwari, Surabhi, Celik, Nafiye Bushra, Rastogi, Ashu, and Garg, Pankaj
- Subjects
- *
POSTERIOR leukoencephalopathy syndrome , *POSITRON emission tomography , *ACUTE coronary syndrome , *HYPERTENSIVE encephalopathy , *MAGNETIC resonance imaging , *TAKOTSUBO cardiomyopathy - Abstract
Objective: Challenging differential diagnosis Background: Pheochromocytoma, a rare catecholamine-secreting tumor, often presents with paroxysmal or sustained hypertension, tachycardia, headache, and diaphoresis. Timely diagnosis is essential to prevent adverse complications. Less common presentations include pheochromocytoma crisis, with severe neurological and cardiac complications. Case Report: We report a unique case of a 25-year-old woman who initially presented with pheochromocytoma-induced hypertensive encephalopathy and acute coronary syndrome. Echocardiography revealed takotsubo-like cardiomyopathy, and magnetic resonance imaging of the brain revealed posterior reversible encephalopathy syndrome. Initial treatment focused on controlling her blood pressure and supporting cardiac function. Due to her recovering from immediate crisis and absence of further symptoms, the patient refused further follow-up. However, she eventually experienced another episode of hypertensive crisis 2 years later. Subsequent investigations with 24-h urine tests revealed elevated vanillylmandelic acid levels (7.93 mg/24 h), normetanephrine (2638.72 µg/24 h), and nor-metanephrine to creatinine ratio (3546.67) and normal urine metanephrine levels (195.92 µg/24 h) and metanephrine to creatinine ratio (263.33). Contrast-enhanced computed tomography of the abdomen revealed a 4.3 x 3.1 x 4-cm mass in the right adrenal gland. A DOTATATE positron emission tomography scan revealed a 3.9 x 4.3 x 2.7-cm localized right adrenal pheochromocytoma. Biochemical testing and adrenal imaging revealed a previously undiagnosed pheochromocytoma. Following targeted medical therapy and right adrenalectomy, the patient achieved complete resolution of her hypertension and associated symptoms. Conclusions: Our case is a unique simultaneous presentation of posterior reversible encephalopathy syndrome and takotsubo- like cardiomyopathy, highlighting the importance to consider pheochromocytoma in acute neurological and cardiac presentations, even in the absence of typical symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Clinical perspectives: Takotsubo cardiomyopathy.
- Author
-
Ravindran, Jayant and Brieger, David
- Abstract
Takotsubo syndrome is a condition characterised by temporary acute left ventricular dysfunction with regional wall abnormalities extending beyond a single coronary artery territory. Initially thought to be benign, this condition, which is challenging to distinguish from acute coronary syndrome, has substantial morbidity and mortality. The mechanism behind this condition remains elusive, but multiple theories have been proposed. Although beta blockers and angiotensin‐converting enzyme inhibitors are used as treatments for left ventricular dysfunction, currently, there are no randomised controlled trials to support their use. In this paper, we review the latest evidence regarding aetiologies, pathophysiology, diagnostic criteria, prognosis, complications and management of Takotsubo syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Takotsubo Cardiomyopathy Mimicking Obstructive Hypertrophic Cardiomyopathy.
- Author
-
Zekeriyeyev, Samuray and Canpolat, Uğur
- Abstract
Copyright of Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
17. Incidence of Takotsubo cardiomyopathy in patients with acute coronary syndrome: a single center retrospective analysis.
- Author
-
Poruban, Tibor, Studencan, Martin, Kirsch, Peter, and Novotny, Robert
- Abstract
Background: Takotsubo cardiomyopathy (TTC) is an acute and usually reversible condition that often mimics the course of acute coronary syndrome (ACS), making it particularly challenging to differentiate, especially in the initial phases. In this study, we retrospectively analyzed the incidence, clinical course, examination results, and in-hospital mortality of TTC in patients with ACS hospitalized at our cardiology center from January 2018 to October 2023. Results: During the study period, a total of 3835 selective coronary angiograms were urgently performed at our facility, with a diagnosis of TTC established in 52 (1.35%) patients, the majority of whom were females—48 (93%), with an average age of 64.2 ± 10.2 years. Stress-induced mechanisms were identified in 36 (69%) patients. The most common symptom was chest pain (86.5%). Electrocardiographic changes primarily included ST-segment elevations (61.6%) and depressions (14%). The average left ventricular ejection fraction was 45.1 ± 8.3 (33–57%), typically with an echocardiographic pattern of apical ballooning dysfunction followed by midventricular dyskinesia. In-hospital mortality was zero. Conclusions: TTC is a reversible condition with a low incidence of complications. Its occurrence in our patient cohort is lower compared to international registries. However, as demonstrated in this study, it is associated with significant in-hospital morbidity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Takotsubo Syndrome and Gender Differences: Exploring Pathophysiological Mechanisms and Clinical Differences for a Personalized Approach in Patient Management.
- Author
-
Giubilato, Simona, Francese, Giuseppina Maura, Manes, Maria Teresa, Rossini, Roberta, Della Bona, Roberta, Gatto, Laura, Di Monaco, Antonio, Zilio, Filippo, Gasparetto, Nicola, Sorini Dini, Carlotta, Borrello, Francesco, Mannarini, Antonia, Scardovi, Angela Beatrice, Pavan, Daniela, Amico, Francesco, Geraci, Giovanna, Riccio, Carmine, Colivicchi, Furio, Grimaldi, Massimo, and Gulizia, Michele Massimo
- Subjects
- *
TAKOTSUBO cardiomyopathy , *SYMPATHETIC nervous system , *ACUTE coronary syndrome , *CORONARY artery disease , *GENDER inequality - Abstract
Takotsubo syndrome (TTS), also known as the broken-heart syndrome, is a reversible condition typically observed in female patients presenting for acute coronary syndromes (ACS). Despite its increasing incidence, TTS often remains undiagnosed due to its overlap with ACS. The pathophysiology of TTS is complex and involves factors such as coronary vasospasm, microcirculatory dysfunction, increased catecholamine levels, and overactivity of the sympathetic nervous system. Diagnosing TTS requires a comprehensive approach, starting with clinical suspicion and progressing to both non-invasive and invasive multimodal tests guided by a specific diagnostic algorithm. Management of TTS should be personalized, considering potential complications, the presence or absence of coronary artery disease (CAD), diagnostic test results, and the patient's clinical course. The current data primarily derive from case series, retrospective analyses, prospective registries, and expert opinions. In recent years, there has been growing recognition of gender differences in the pathophysiology, presentation, and outcomes of TTS. This review provides an updated overview of gender disparities, highlighting the importance of tailored diagnostic and management strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Takotsubo Syndrome: Differences between Peripartum Period and General Population.
- Author
-
Tzerefos, Stavros, Aloizou, Dimitra, Nikolakopoulou, Sofia, and Aloizos, Stavros
- Subjects
HORMONES ,PUERPERIUM ,BLOOD vessels ,COMPUTED tomography ,MENTAL illness ,TAKOTSUBO cardiomyopathy ,MAGNETIC resonance imaging ,ROUTINE diagnostic tests ,INTENSIVE care units ,PSYCHOLOGICAL stress ,CORONARY angiography ,PERINATAL period ,GENETICS ,BIOMARKERS ,ECHOCARDIOGRAPHY ,DISEASE risk factors ,DISEASE complications ,SYMPTOMS ,PREGNANCY - Abstract
Takotsubo syndrome (TTS) was first described in postmenopausal women with transient regional wall motion abnormalities. The trigger is usually an emotional or physical stress. The catecholamine hypothesis seems to be the most prevailing. The main difference between TTS and acute coronary syndromes is that there is no obstructive coronary disease to explain the regional abnormalities. In this form, the left ventricle resembles the fishing jar which is used to trap octopus in Japan. However, to date more atypical forms are recognized. Also, the syndrome is not limited to older women. Nowadays, TTS is presented even in pregnancy and postpartum females. Our experience revealed cases of patients during these periods and some of them suffered from reverse Takotsubo. Additionally, the initial diagnosis in some patients was other than TTS. Due to these findings, we suggest that this type of TTS is not very rare but underestimated. For this reason, further studies are needed to support and explain this condition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system.
- Author
-
Liangxia Li, Qianqian Xu, Yarui Liu, Liangfang Pang, Zhou Cui, and Yuanyuan Lu
- Subjects
NEUROMUSCULAR blocking agents ,KOUNIS syndrome ,ANAPHYLAXIS ,VENTRICULAR fibrillation ,TAKOTSUBO cardiomyopathy - Abstract
Background: Neuromuscular blocking agents (NMBAs) are primarily used during surgical procedures to facilitate endotracheal intubation and optimize surgical conditions. This study aimed to explore the adverse event signals of NMBAs, providing reference for clinical safety. Methods: This study collected reports of atracurium, cisatracurium, rocuronium, and vecuronium as primary suspect drugs in The US Food and Drug Administration Adverse Event Reporting System (FAERS) from the first quarter of 2004 to the third quarter of 2023. The adverse events (AEs) reported in the study were retrieved based on the Preferred Terms (PTs) of the Medical Dictionary for Regulatory Activities. In addition, we conducted disproportionality analysis on relevant reports using the reporting odds ratio (ROR) method and Bayesian confidence propagation neural network (BCPNN) method. A positive signal was generated when both algorithms show an association between the target drug and the AE. Results: A total of 11,518 NMBA-related AEs were reported in the FAERS database. The most AEs of rocuronium were collected. NMBA-related AEs involved 27 different system organs (SOCs), all of the four NMBAs had positive signals in “cardiac disorders,” “immune system disorders,” “respiratory, thoracic and mediastinal disorders” and “vascular disorders.” At the PTs level, a total of 523 effective AEs signals were obtained for the four NMBAs. AEs labled in the instructions such as anaphylaxis (include anaphylactic reaction and anaphylactic shock), bronchospasm, respiratory arrest and hypotension were detected positive signals among all NMBAs. In addition, we also found some new AEs, such as ventricular fibrillation for the four NMBAs, hyperglycaemia for atracurium, kounis syndrome and stress cardiomyopathy for rocuronium, hepatocellular injury for cisatracurium, hyperkalaemia for vecuronium. To further investigated the AEs associated with serious clinical outcomes, we found that cardiac arrest and anaphylaxis were the important risk factors for death due to NMBAs. Conclusion: NMBA-related AEs have a significant potential to cause clinically severe consequences. Our study provides valuable references for the safety profile of NMBAs, and considering the limitations of the FAERS database, further clinical data are needed to validate the findings of this study. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Recurrent Takotsubo Syndrome: How Frequent, and How Does It Present?
- Author
-
Looi, Jen-Li, Easton, Aleisha, Webster, Mark, To, Andrew, Lee, Mildred, and Kerr, Andrew J.
- Subjects
- *
TAKOTSUBO cardiomyopathy , *PATIENTS' attitudes , *HOSPITAL admission & discharge , *ECHOCARDIOGRAPHY - Abstract
Recurrent Takotsubo syndrome (TS) is not uncommon but experience with TS recurrence is inherently limited by the infrequency of the condition itself and incomplete long-term follow-up. There is limited published data on the clinical features and outcomes of patients with recurrent TS. We aimed to describe the clinical characteristics and outcomes of patients with recurrent TS in a large Auckland cohort. The clinical profile, in-hospital, and long-term outcomes were prospectively assessed in consecutive patients with recurrent TS presenting to Auckland's three major hospitals between January 2006 and January 2023. During the study period, 472 TS patients were identified. Of the 467 patients discharged alive after the index event, 45 (9.6%) patients (mean age 62.3±11.0 years), all women, experienced recurrent TS. Median time interval from index event to the first recurrence was 3.14 years (range 27 days to 13.8 years). In 27 (60%) of the 45 patients, the subsequent events involved a stressor (physical triggers, n=8; emotional triggers, n=19). The stressor type differed between the index and recurrent event in 18 (40%) of the 45 patients. Thirteen (28.9%) had a different echocardiographic variant of TS at first recurrence. All patients with recurrent TS were discharged alive. Four patients died late after discharge from the first recurrence, all but one from a non-cardiac cause. One in 10 patients with TS experience recurrent events. These may occur many years later, and both the stressor type and the echocardiographic variant may be different at the recurrent event. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator Survey.
- Author
-
Youssef, Gilbert, Acquaye-Mallory, Alvina, Vera, Elizabeth, Chheda, Milan G, Dunn, Gavin P, Moliterno, Jennifer, O'Brien, Barbara J, Venere, Monica, Yust-Katz, Shlomit, Lee, Eudocia Q, and Armstrong, Terri S
- Subjects
- *
JOB satisfaction , *PSYCHOLOGICAL burnout , *DEPERSONALIZATION , *PSYCHOLOGICAL stress , *JOB stress , *UNIVARIATE analysis , *TAKOTSUBO cardiomyopathy - Abstract
Background Burnout is a syndrome characterized by emotional exhaustion, depersonalization, and a reduced sense of accomplishment, which commonly arises from chronic workplace stress in the medical field. Given the higher risk of burnout in younger age groups reported in some studies, the Society for Neuro-Oncology (SNO) Young Investigator (YI) and Wellness Committees combined efforts to examine burnout in the SNO YI membership to better understand and address their needs. Methods We distributed an anonymous online survey to SNO members in 2019. Only those meeting the definition of a YI were asked to complete the survey. The survey consisted of questions about personal and professional characteristics as well as the validated Maslach Burnout Inventory-Human Services Survey (MBI-HSS) questionnaire. Statistical analyses included descriptive statistics, univariate and multivariate analyses, and incorporation of previously defined burnout profiles. Results Data were analyzed for 173 participants who self-identified as YI. Measures of burnout showed that YI members scored higher on emotional exhaustion and depersonalization compared to normative population but similar to those in a prior SNO general membership survey. With respect to burnout profiles, 30% of YI respondents classified as overextended and 15% as burnout. Organizational challenges were the most common contributors to stress. Conclusions Similar to results from a previous survey completed by general SNO membership, the prevalence of burnout among neuro-oncology clinical and research YI is high, and is mainly characterized by overextension, warranting interventions at institutional and organizational levels. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
23. Case report: Coexistence of takotsubo syndrome and severe mononeuritis multiplex in rheumatoid vasculitis.
- Author
-
Acar, Emre Ali, Uslu, Sadettin, Gemici, Yagmur Inalkac, Cetin, Nurullah, Temiz, Peyker, and Gündüz, Ozgül Soysal
- Subjects
- *
SEX factors in disease , *ETIOLOGY of diseases , *ACUTE phase reaction , *ACUTE phase proteins , *PERIPHERAL vascular diseases , *TAKOTSUBO cardiomyopathy - Abstract
This article presents a case study of a 55-year-old woman with rheumatoid arthritis who developed complications known as rheumatoid vasculitis (RV). The patient experienced symptoms such as fatigue, muscle pain, and weight loss, and was initially diagnosed with vasculitis. However, she later developed numbness and weakness in her hands and feet, which was diagnosed as severe mononeuritis multiplex. The article provides detailed information on the patient's laboratory findings and electrophysiological values. It emphasizes the importance of early recognition and treatment of RV, as it can lead to significant morbidity and mortality. The authors also call for further research and understanding of this condition. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
24. Shark fin sign: A rare EKG finding in a patient with Takotsubo cardiomyopathy from influenza A infection.
- Author
-
Wattanachayakul, Phuuwadith, Jones, Colton, Malin, John, Mohan, Nandakumar, Manzano, Jose Martinez, Akuna, Emmanuel, and Amanullah, Aman
- Subjects
- *
TAKOTSUBO cardiomyopathy , *CARDIOGENIC shock , *MULTIPLE organ failure , *INFLUENZA , *SHARKS - Abstract
Key Clinical Message: This case demonstrated the rare "shark fin" ECG pattern, an ST‐segment elevation typically seen in acute myocardial infarction. We reported a case of takotsubo cardiomyopathy secondary to influenza A infection with multiple organ failure, showing the shark fin sign and resulting in in‐patient mortality and various complication. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Takotsubo syndrome in a cancer patient treated with a combination of anti-cancer drugs including immune checkpoint inhibitors: a case report.
- Author
-
Yamada, Keita, Ida-Ichikawa, Mizuki, Fujimoto, Naoki, Ishida, Masaki, and Dohi, Kaoru
- Subjects
IMMUNE checkpoint inhibitors ,ANTINEOPLASTIC agents ,TAKOTSUBO cardiomyopathy ,CARDIAC magnetic resonance imaging ,BRAIN natriuretic factor ,MAGNETIC resonance imaging - Abstract
Background Takotsubo syndrome (TTS) is characterized by transient regional left ventricular (LV) dysfunction occurring in individuals exposed to physical or emotional stress. Various stressors are triggers for TTS in cancer patients, and anti-cancer drugs have recently been proposed as a trigger. Therefore, further studies are needed to clarify these triggers and avoid the unnecessary interruption of anti-cancer treatment. Case summary A 66-year-old woman presented with dyspnoea 10 days after the initiation of atezolizumab in combination with bevacizumab. She had previously received osimertinib as first-line therapy for recurrent lung cancer after primary resection and atezolizumab in combination with bevacizumab, paclitaxel, and carboplatin as second-line therapy. She was admitted due to electrocardiography abnormalities and elevated troponin I and brain natriuretic peptide levels. Echocardiography revealed circumferential severe LV hypokinesis at the mid-ventricular level, with preserved wall motion at the base and apex. Cardiac catheterization performed after the attenuation of symptoms with 20 mg of intravenous furosemide showed normal coronary arteries. Cardiac magnetic resonance imaging on Day 4 revealed increases in T
1 and T2 values and extracellular volume fraction; however, neither myocardial infiltration of inflammatory cells or myocardial necrosis was observed in endomyocardial samples obtained on the day of her arrival. Atypical TTS was suspected, and she was treated with perindopril, bisoprolol, and spironolactone. Magnetic resonance imaging 1.5 months after the onset of TTS showed improvements in LV contractility, T1 and T2 values, and the extracellular volume fraction. Discussion A more detailed understanding of the relationship between anti-cancer drugs and TTS is crucial for preventing interruptions to anti-cancer therapy. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
26. Takotsubo syndrome after bilateral simultaneous total knee arthroplasty - A case report.
- Author
-
Soundarrajan, Dhanasekaran, Singh, Rithika, Subramaniam, Muthiah, Dhanasekararaja, Palanisami, Rajkumar, Natesan, and Rajasekaran, Shanmuganathan
- Subjects
DIFFERENTIAL diagnosis ,TAKOTSUBO cardiomyopathy ,SURGICAL complications ,BRADYCARDIA ,ELECTROCARDIOGRAPHY ,TOTAL knee replacement ,CORONARY angiography ,HYPOTENSION ,ECHOCARDIOGRAPHY - Abstract
Cardiac complications represents a major cause of morbidity and mortality especially after bilateral simultaneous total knee arthroplasty (BS-TKA). Takotsubo syndrome after BS-TKA has not been described in the literature. A 60 years-old women underwent BS- TKA and she suddenly developed bradycardia and hypotension after second knee wound closure. The electrocardiography revealed ST elevation and echocardiography showed apical hypokinesia of left ventricle. Coronary angiography revealed normal epicardial coronaries and a provisional diagnosis of Takotsubo cardiomyopathy was made. Serial ECGs revealed resolution of ST elevation and normal LV function within 5 days. On one-year follow up, she was able to do all her normal activities, and 12-lead electrocardiography were back to normal. Cardiac complications represents a major cause of morbidity and mortality especially after BS-TKA. Surgeons must be vigilant in the postoperative period for any likely precipitating factors of stress induced cardiomyopathy. Takotsubo syndrome should be considered as a differential diagnosis with features of acute coronary syndrome in elderly post-menopausal patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Exercise limitation in hypertrophic cardiomyopathy: combined stress echocardiography and cardiopulmonary exercise test.
- Author
-
Erez, Yonatan, Ghantous, Eihab, Shetrit, Aviel, Zamanzadeh, Ryan S., Zahler, David, Granot, Yoav, Sapir, Orly Ran, Laufer Perl, Michal, Banai, Shmuel, Topilsky, Yan, and Havakuk, Ofer
- Subjects
EXERCISE tests ,STRESS echocardiography ,AEROBIC capacity ,TAKOTSUBO cardiomyopathy ,HYPERTROPHIC cardiomyopathy - Abstract
Aims: The study aims to investigate exercise‐limiting factors in hypertrophic cardiomyopathy (HCM) using combined stress echocardiography and cardiopulmonary exercise test. Methods and results: A symptom‐limited ramp bicycle exercise test was performed in the semi‐supine position on a tilting dedicated ergometer. Echocardiographic images were obtained concurrently with gas exchange measurements along predefined stages of exercise. Oxygen extraction was calculated using the Fick equation at each activity level. Thirty‐six HCM patients (mean age 67 ± 6 years, 72% men, 18 obstructive HCM) were compared with age and sex‐matched 29 controls. At rest, compared with controls, E/E′ ratio (6.26 ± 2.3 vs. 14 ± 2.5, P < 0.001) and systolic pulmonary artery pressures (SPAP) (22.6 ± 3.4 vs. 34 ± 6.2 mmHg, P = 0.023) were increased. Along with the stages of exercise (unloaded; anaerobic threshold; peak), diastolic function worsened (E/e′ 8.9 ± 2.6 vs. 13.8 ± 3.6 P = 0.011; 9.4 ± 2.3 vs. 18.6 ± 3.3 P = 0.001; 8.7 ± 1.9 vs. 21.5 ± 4, P < 0.001), SPAP increased (23 ± 2.7 vs. 33 ± 4.4, P = 0.013; 26 ± 3.2 vs. 40 ± 2.9, P < 0.001; 26 ± 3.5 vs. 45 ± 7 mmHg, P < 0.001), and oxygen consumption (6.6 ± 1.7 vs. 6.8 ± 1.6, P = 0.86; 18.1 ± 2.2 vs. 14.6 ± 1.5, P = 0.008; 20.3 ± 3 vs. 15.1 ± 2.1 mL/kg/min, P = 0.01) was reduced. Oxygen pulse was blunted (6.3 ± 1.8 vs. 6.2 ± 1.9, P = 0.79; 10 ± 2.1 vs. 8.8 ± 1.6, P = 0.063; 12.2 ± 2 vs. 8.2 ± 2.3 mL/beat, P = 0.002) due to an insufficient increase in both stroke volume (92.3 ± 17 vs. 77.3 ± 14.5 P = 0.021; 101 ± 19.1 vs. 87.3 ± 15.7 P = 0.06; 96.5 ± 12.2 vs. 83.6 ± 16.1 mL, P = 0.034) and oxygen extraction (0.07 ± 0.03 vs. 0.07 ± 0.02, P = 0.47; 0.13 ± 0.02 vs. 0.10 ± 0.03, P = 0.013; 0.13 ± 0.03 vs. 0.11 ± 0.03, P = 0.03). Diastolic dysfunction, elevated SPAP, and the presence of atrial fibrillation were associated with reduced exercise capacity. Conclusions: Both central and peripheral cardiovascular limitations are involved in exercise intolerance in HCM. Diastolic dysfunction seems to be the main driver for this limitation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Ceruloplasmin and Lipofuscin Serum Concentrations Are Associated with Presence of Hypertrophic Cardiomyopathy.
- Author
-
Smyła-Gruca, Wiktoria, Szczurek-Wasilewicz, Wioletta, Skrzypek, Michał, Romuk, Ewa, Karmański, Andrzej, Jurkiewicz, Michał, Gąsior, Mariusz, Osadnik, Tadeusz, Banach, Maciej, Jóźwiak, Jacek J., and Szyguła-Jurkiewicz, Bożena
- Subjects
RECEIVER operating characteristic curves ,TAKOTSUBO cardiomyopathy ,HYPERTROPHIC cardiomyopathy ,OXIDATIVE stress ,REACTIVE oxygen species - Abstract
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and cells' ability to neutralize them by antioxidant systems. The role of oxidative stress in hypertrophic cardiomyopathy (HCM) is not fully understood. The aim of the study was to examine selected parameters of oxidative stress in patients with HCM compared to the control group. We enrolled 85 consecutive HCM patients and 97 controls without HCM. The groups were matched for sex, the body mass index, and age. Oxidative stress markers included superoxide dismutase (SOD), ceruloplasmin (CER), and lipofuscin (LPS). The median age of the HCM patients was 53 (40–63) years, and 41.2% of them were male. HCM patients, compared to the control ones, had significantly increased levels of CER and LPS. The areas under the receiver operating characteristics curves (AUC) indicated a good discriminatory power of CER (AUC 0.924, sensitivity 84%, and specificity 88%), an acceptable discriminatory power of LPS (AUC 0.740, sensitivity 66%, and specificity 72%), and poor discriminatory power of SOD (AUC 0.556, sensitivity 34%, and specificity 94%) for HCM detection. CER with good predictive strength, as well as LPS with acceptable predictive power, allows for HCM detection. The utility of SOD for HCM detection is limited. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Cardiac Angiosarcoma in the Right Atrium Treated by Surgical Resection.
- Author
-
Dragicevic-Antonic, Milica, Rankovic-Nicic, Ljiljana, Stamenkovic, Gordana, Petrovic, Masa, Loncar, Goran, Markovic, Nikola, Dimitrijevic, Ana, Bulatovic, Sulin, Cirkovic, Milan, Borzanovic, Branislava, Antonic, Zelimir, Pirnat, Maja, Manka, Robert, and Bojic, Milovan
- Subjects
CARDIAC magnetic resonance imaging ,RIGHT heart atrium ,VENA cava superior ,TAKOTSUBO cardiomyopathy ,ADJUVANT chemotherapy ,ANGIOSARCOMA - Abstract
We present the case of a 49-year-old female of Caucasian European descent with chest tightness, fatigue, and palpitations, ultimately diagnosed with primary intracardiac angiosarcoma. Initial echocardiography revealed a significant mass within the right atrium, infiltrating the free wall. Surgical intervention included tumor excision and partial resection of the superior vena cava. Histopathological examination confirmed a high-grade angiosarcoma. Postoperative imaging identified a recurrent mass in the right atrium, suggestive of thrombus, alongside Takotsubo cardiomyopathy. Considering the elevated surgical risks and the presence of cardiomyopathy, management included anticoagulation therapy with Warfarin and adjuvant chemotherapy with Paclitaxel. Follow-up cardiac magnetic resonance imaging demonstrated a recurrent angiosarcoma with superimposed thrombus. This case presents the complex diagnostic and therapeutic landscape of angiosarcoma, highlighting the critical importance of early surgical intervention, advanced imaging techniques, and vigilant postoperative monitoring. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Reverse takotsubo induced cardiogenic shock in the peripartum period: A case report and literature review.
- Author
-
Gregory, James and Uzuner, Cansu
- Subjects
- *
PERINATAL period , *LITERATURE reviews , *CARDIOGENIC shock , *TAKOTSUBO cardiomyopathy , *TRANSIENTS (Dynamics) , *CESAREAN section - Abstract
Reverse takotsubo cardiomyopathy is a rare variant of a rare disease characterized by basal ballooning and dysfunction of the left ventricle. While it can render patients profoundly unwell and reliant on intensivist care, it is a transient phenomenon, with the worst symptoms subsiding after 2–3 days. At term, a young woman spontaneously entered labor prior to a planned repeat cesarean section. After experiencing physical and psychological distress during labor and a vacuum extraction, she developed cardiogenic shock from reverse takotsubo cardiomyopathy, quickly diagnosed with transthoracic echocardiogram. She required 2 days of intensive care support and made an excellent recovery. This very rare condition should be considered in systemically unwell women in the peripartum as it can be quickly diagnosed, providing patients with the best appropriate care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. Heat Shock Protein 70 Constitutes a Promising Novel Biomarker in Differential Diagnosis between Takotsubo Syndrome and Non-ST-Segment Elevation Myocardial Infarction.
- Author
-
Demirel, Ozan, Paar, Vera, Tolnai, Philipp, Topf, Albert, Hoppe, Uta C., Lichtenauer, Michael, and Mirna, Moritz
- Subjects
- *
LOGISTIC regression analysis , *HEAT shock proteins , *ACUTE coronary syndrome , *NON-ST elevated myocardial infarction , *SYMPTOMS - Abstract
(1) Background: Due to similar clinical presentation and a lack of specific biomarkers, initial differentiation between Takotsubo syndrome (TTS) and non-ST-segment elevation myocardial infarction (NSTEMI) remains challenging in daily practice. Heat Shock Protein 70 (HSP70) is a novel biomarker that is recognized for its potential in the diagnosis and differentiation of cardiovascular conditions. (2) Methods: Data from a total of 156 patients were analyzed (32.1% NSTEMI, 32.7% TTS, and 35.3% controls). Serum concentrations of HSP70 were determined using ELISA and compared between patients and controls. ROC curve analysis, logistic regression analysis and propensity-score-weighted logistic regression were conducted. (3) Results: Concentrations of HSP70 were highest in patients with TTS (median 1727 pg/mL vs. ACS: median 1545 pg/mL vs. controls: median 583 pg/mL, p < 0.0001). HSP70 was predictive for TTS in binary logistic regression analysis (B(SE) = 0.634(0.22), p = 0.004), which even remained significant after correction for possible confounders in propensity-score-weighted analysis. ROC curve analysis also revealed a significant association of HSP70 with TTS (AUC: 0.633, p = 0.008). (4) Conclusions: Based on our findings, HSP70 constitutes a promising biomarker for discrimination between TTS and NSTEMI, especially in combination with established cardiovascular biomarkers like pBNP or high-sensitivity cardiac troponin. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Perioperative management of Takotsubo cardiomyopathy: an overview.
- Author
-
Pillitteri, Marta, Brogi, Etrusca, Piagnani, Chiara, Bozzetti, Giuseppe, and Forfori, Francesco
- Subjects
TAKOTSUBO cardiomyopathy ,MEDICAL care ,MYOCARDIUM ,PSYCHOLOGICAL stress ,ELECTIVE surgery ,CRITICALLY ill - Abstract
Resembling the morphology of Japanese polyp vessels, the classic form of Takotsubo cardiomyopathy is characterized by the presence of systolic dysfunction of the mid-apical portion of the left ventricle associated with basal hyperkinesia. It is believed that this may be due to a higher density of β-adrenergic receptors in the context of the apical myocardium, which could explain the greater sensitivity of the apex to fluctuations in catecholamine levels. The syndrome is precipitated by significant emotional stress or acute severe pathologies, and it is increasingly diagnosed during the perioperative period. Indeed, surgery, induction of general anaesthesia and critical illness represent potential harmful trigger of stress cardiomyopathy. No universally accepted guidelines are currently available, and, generally, the treatment of TTS relies on health care personal experience and/or local practice. In our daily practice, anaesthesiologists can be asked to manage patients with the diagnosis of new-onset Takotsubo before elective surgery or an emergent surgery in a patient with a concomitant stress cardiomyopathy. Even more, stress cardiomyopathy can arise as a complication during the operation. In this paper, we aim to provide an overview of Takotsubo syndrome and to discuss how to manage Takotsubo during surgery and in anaesthesiologic special settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Zolpidem-triggered atrial fibrillation in a patient with cardiomyopathy: a case report.
- Author
-
Li, Xiaolin and Jin, Yunpeng
- Subjects
ATRIAL fibrillation ,CARDIOVASCULAR agents ,TAKOTSUBO cardiomyopathy ,CARDIOMYOPATHIES ,ATTEMPTED suicide ,ZOLPIDEM ,CHEST pain - Abstract
Background: Zolpidem is a non-benzodiazepine hypnotic widely used to manage insomnia. Zolpidem-triggered atrial fibrillation (AF) in patients with cardiomyopathy has never been reported before. Case presentation: A 40-year-old man with Duchenne muscular dystrophy-related cardiomyopathy attempted suicide and developed new-onset AF after zolpidem overdose. One year before admission, the patient visited our clinic due to chest discomfort and fatigue after daily walks for 1 month; both electrocardiography (ECG) and 24-hour Holter ECG results did not detect AF. After administration of cardiac medication (digoxin 0.125 mg/day, spironolactone 40 mg/day, furosemide 20 mg/day, bisoprolol 5 mg/day, sacubitril/valsartan 12/13 mg/day), he felt better. AF had never been observed before this admission via continuous monitoring during follow-up. Sixteen days before admission, the patient saw a sleep specialist and started zolpidem tartrate tablets (10 mg/day) due to insomnia for 6 months; ECG results revealed no significant change. The night before admission, the patient attempted suicide by overdosing on 40 mg of zolpidem after an argument, which resulted in severe lethargy. Upon admission, his ECG revealed new-onset AF, necessitating immediate cessation of zolpidem. Nine hours into admission, AF spontaneously terminated into normal sinus rhythm. Results from the ECG on the following days and the 24-hour Holter ECG at 1-month follow-up showed that AF was not detected. Conclusions: This study provides valuable clinical evidence indicating that zolpidem overdose may induce AF in patients with cardiomyopathy. It serves as a critical warning for clinicians when prescribing zolpidem, particularly for patients with existing heart conditions. Further large-scale studies are needed to validate this finding and to explore the mechanisms between zolpidem and AF. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis.
- Author
-
Tan, Boyu, Chen, Li, Yan, Sulan, Pan, Huijie, Zhang, Jingxian, and Wei, Hongyan
- Subjects
- *
SEROTONIN uptake inhibitors , *TAKOTSUBO cardiomyopathy , *SEROTONIN , *ANTIDEPRESSANTS , *FLUOXETINE , *LIKELIHOOD ratio tests , *VENLAFAXINE - Abstract
Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are reported to cause stress cardiomyopathy (SC). This study evaluated the association between SSRI/SNRI use and the occurrence of cardiomyopathy in the publicly available U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database. Disproportionate analysis and likelihood ratio tests were used to identify risk associated with SSRIs or SNRIs and the incidence of SC, using data from between from 2012 to 2022 acquired from the FAERS database. The study identified 132 individual case safety reports (ICSRs) of SC associated with SSRIs or SNRIs. Venlafaxine (48%) and fluoxetine (27%) were the most common antidepressants of the ICSRs. Approximately 80% of SC cases were reported in females, with individuals aged 45–65 years identified as a high-risk population. Both venlafaxine (ratio-scale information component [RSIC] 2.54, 95% CI 2.06–3.04) and fluoxetine (RSIC 3.20, 95% CI 2.31–4.47) were associated with SC, with likelihood ratio estimates of 3.55 (p = 0.02) for venlafaxine and 4.82 (p = 0.008) for fluoxetine. The median time to cardiomyopathy onset was 20 days, with hospitalization reported in 48.33% of patients. Venlafaxine and fluoxetine were associated with SC risk, particularly in middle-aged women. Caution should be exercised when using SSRIs or SNRIs combined with other serotonergic medications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Update on cirrhotic cardiomyopathy: from etiopathogenesis to treatment.
- Author
-
Yumusak, Ogulcan and Doulberis, Michael
- Subjects
- *
HEART diseases , *PORTAL hypertension , *BOWEL obstructions , *CHRONICALLY ill , *DRUG efficacy , *HEART failure , *TAKOTSUBO cardiomyopathy - Abstract
Cirrhotic cardiomyopathy represents a syndrome of cardiac dysfunction associated with advanced liver disease. It is the result of complex pathophysiological processes that complicate the course of the disease, and is generally associated with a poor prognosis. Pathophysiologically, portal hypertension is the key factor leading to hyperdynamic circulation, via over-activation of the neurohumoral axis. Intestinal obstruction, subclinical inflammation and hepatocellular insufficiency, with defective synthesis or metabolism of several vasoactive mediators, are essential components of this process. Since it is usually unapparent at rest and only unmasked by an inadequate cardiac response to hemodynamic stress, the diagnosis of cirrhotic cardiomyopathy is challenging and demands a multimodal approach. There is currently no specific therapy, but there are prognostically effective drugs available to treat heart failure. Therefore, it is crucial to identify patients with chronic liver disease and heart failure in order to ameliorate their outcome. This article attempts to highlight the most important aspects of cirrhotic cardiomyopathy and draws attention to this condition. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats.
- Author
-
Yang, Guangwei, Liu, Zitian, Dong, Shuohui, Zhao, Xiang, Ge, Zheng, Cheng, Zhiqiang, Zhang, Xiang, and Wang, Kexin
- Subjects
- *
DIABETIC cardiomyopathy , *AMP-activated protein kinases , *TAKOTSUBO cardiomyopathy , *OXIDATIVE stress , *ADENOSINE monophosphate , *JEJUNOILEAL bypass , *LOW-fat diet - Abstract
Background: Diabetic cardiomyopathy is a serious complication of obesity with type 2 diabetes and is a major cause of mortality. Metabolic surgery, such as duodenal‐jejunal bypass (DJB), can effectively improve diabetic cardiomyopathy; however, the underlying mechanisms remain elusive. Oxidative stress is one of the pivotal mechanisms of diabetic cardiomyopathy. Our objective was to investigate the effect and potential mechanisms of DJB on oxidative stress in the heart of diabetic cardiomyopathy rats. Methods: High‐fat diet combined with intraperitoneal injection of streptozotocin was used to establish diabetic cardiomyopathy rats. DJB was performed on diabetic cardiomyopathy rats, and high glucose and palmitate were used to simulate diabetic cardiomyopathy in H9C2 cells in vitro. Sera from different groups of rats were used for experiments in vivo and in vitro. Results: DJB effectively improved oxidative stress and activated the adenosine monophosphate (AMP)‐activated protein kinase (AMPK) pathway to increase endothelial nitric oxide synthase (eNOS) phosphorylation level and the expression of antioxidative system‐related proteins and genes in the heart of diabetic cardiomyopathy rats. AMPK agonists and serum from DJB rats activated the AMPK pathway to increase eNOS phosphorylation level and the expression of antioxidative system‐related proteins and genes and decreased the content of reactive oxygen species in H9C2 cells, but this improvement was almost eliminated by the addition of AMPK inhibitors. Conclusions: DJB activates eNOS and enhances the antioxidant system by activating the AMPK pathway—and not solely by improving blood glucose—to improve oxidative stress in the heart of diabetic cardiomyopathy rats. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Generating and estimating dependency between binary variables.
- Author
-
Ferreira do Nascimento, Igor
- Subjects
- *
TAKOTSUBO cardiomyopathy , *DISTRIBUTION (Probability theory) , *BAYESIAN field theory , *INDEPENDENT variables , *MOMENTS method (Statistics) , *RESAMPLING (Statistics) - Abstract
The assumption that binary variables are independent, homogeneously distributed and exchangeable may not reflect reality. Therefore, the present work proposes a method that transforms a multivariate simulation problem dependent of binary variables into a hierarchical dependency model, which allows for easier estimation and simulation. The dependency estimation via Bayesian Inference outperforms the Method of Moments, since it presents a lower error measure and guarantees non-negative estimates bounded by 1. The complexity estimation via Bayesian approach was overcome by important resampling methods via Monte Carlo. The binary simulation proposal was applied to model the probability of death in family groups, considering the broken heart syndrome, when the death of one member affects the probability distribution of another one. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
38. Takotsubo cardiomyopathy in Guillain–Barré syndrome.
- Author
-
Terayama, Atsushi, Kuwahara, Motoi, Yoshikawa, Keisuke, Yamagishi, Yuko, Samukawa, Makoto, Yamashita, Shoko, Onishi, Kyohei, Nagano, Tomoya, Tatsumi, Chikao, Ishii, Junko, Kawamoto, Michi, Tokashiki, Takashi, Deguchi, Shoko, Deguchi, Kentaro, Ishida, Atsushi, Baba, Yasuhiko, Yamaguchi, Shigeki, Kusunoki, Susumu, and Nagai, Yoshitaka
- Subjects
- *
TAKOTSUBO cardiomyopathy , *GUILLAIN-Barre syndrome , *CRANIAL nerves , *AGE of onset , *ARTIFICIAL respiration - Abstract
Background and purpose: Takotsubo cardiomyopathy (TCM) is a serious autonomic complication of Guillain–Barré syndrome (GBS). However, the association between TCM and GBS has not been investigated in detail. We investigated the characteristics of GBS patients with TCM (GBS-TCM). Methods: Clinical features and anti-ganglioside antibody between the GBS-TCM patients and 62 classical GBS patients without TCM as control patients were compared. Results: Eight GBS-TCM patients were identified, in whom TCM was diagnosed at a mean of 6.5 [range 3–42] days after the onset of GBS. The age at onset of GBS was elder in the GBS-TCM patients than in the control GBS patients (76.5 [56–87] vs. 52 [20–88] years, p < 0.01). Notably, cranial nerve deficits, particularly in the lower cranial nerves, were observed in all GBS-TCM patients (100% vs. 41.9%, p < 0.01). Additionally, the GBS-TCM patients showed a higher GBS disability score at nadir (5 [4–5] vs. 4 [1–5], p < 0.01), and lower Medical Research Council sum scores at admission and nadir (37 [30–44] vs. 48 [12–60] at admission, p < 0.05, and 20 [12–44] vs. 40 [0–60] at nadir, p < 0.05, respectively). Mechanical ventilation was more frequently required in the GBS-TCM patients (62.5% vs. 11.3%, p < 0.01). Three GBS-TCM patients were positive for anti-ganglioside antibodies. Conclusions: TCM occurred at a relatively early phase of GBS. The characteristics of GBS-TCM were the elder, lower cranial nerve involvements, severe limb weakness, and respiratory failure. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. How to Use Cardiac Magnetic Resonance Imaging in Myocardial Infarction With Nonobstructive Coronary Arteries.
- Author
-
Tornvall, Per, Beltrame, John F., Nickander, Jannike, Sörensson, Peder, Reynolds, Harmony R., and Agewall, Stefan
- Abstract
The working diagnosis Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA) is being increasingly recognized with the common use of high-sensitivity troponins and coronary angiography, accounting for 5% to 10% of all acute myocardial infarction presentations. Cardiac magnetic resonance (CMR) imaging is pivotal in patients presenting with suspected MINOCA, mainly to delineate those with a nonischemic cause, for example, myocarditis and Takotsubo syndrome, from those with true ischemic myocardial infarction, that is, MINOCA. The optimal timing for CMR imaging in patients with suspected MINOCA has been uncertain and, until recently, not been examined prospectively. Previous retrospective studies have indicated that the diagnostic yield decreases with time from the acute event. The SMINC studies (Stockholm Myocardial Infarction with Normal Coronaries) show that CMR should be performed early in all patients with the working diagnosis of MINOCA, with the possible exception of patients who are clearly identified as having Takotsubo syndrome as determined by echocardiography. In addition to CMR imaging, other investigations of importance in selected patients may be pulmonary artery computed tomography to exclude pulmonary embolism, optical coherence tomography to identify plaque disruption, and acetylcholine provocation to identify coronary artery spasm. Imaging of patients with the working diagnosis MINOCA, which is centered on CMR together with supplemental investigations, results in a clear diagnosis in approximately threequarters of the patients. This is a good example of personalized medicine, because a correct diagnosis will not only increase the satisfaction of the individual patient but also result in optimizing treatment without harming the patient. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Cardiac biomarkers for diagnosing Takotsubo syndrome.
- Author
-
Schweiger, Victor, Vece, Davide Di, Cammann, Victoria L, Koleva, Iva, Würdinger, Michael, Gilhofer, Thomas, Rajman, Katja, Szawan, Konrad A, Niederseer, David, Citro, Rodolfo, Vecchione, Carmine, Bossone, Eduardo, Gili, Sebastiano, Neuhaus, Michael, Franke, Jennifer, Meder, Benjamin, Jaguszewski, Miłosz, Noutsias, Michel, Knorr, Maike, and Jansen, Thomas
- Subjects
TAKOTSUBO cardiomyopathy ,ST elevation myocardial infarction ,BIOMARKERS ,DIAGNOSIS - Abstract
This article examines the use of cardiac biomarkers to diagnose Takotsubo syndrome (TTS), a condition characterized by abnormal left ventricular wall motion. The study validates previously proposed ratios of cardiac biomarkers in distinguishing TTS from acute coronary syndrome (ACS) using data from the International Takotsubo (InterTAK) Registry. The results indicate that these ratios have moderate success in accurately diagnosing TTS, with values ranging from 0.5 to 0.8 on the receiver-operating characteristic (ROC) curve. The study emphasizes the need for new biomarkers to improve TTS diagnosis. The article also includes financial disclosures from the authors, ensuring transparency and avoiding conflicts of interest. The authors state that they have no funding for the current contribution and have obtained ethical approval for the study, providing the pre-registered clinical trial number. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
41. Pediatric takotsubo cardiomyopathy: A review and insights from a National Multicentric Registry.
- Author
-
Vazirani, Ravi, Rodríguez-González, Moisés, Castellano-Martinez, Ana, Andrés, Mireia, Uribarri, Aitor, Corbí-Pascual, Miguel, Alfonso, Fernando, Blanco-Ponce, Emilia, Lluch-Requerey, Carmen, Fernández-Cordón, Clara, Almendro-Delia, Manuel, Cruz, Oscar Vedia, and Núñez-Gil, Iván J.
- Subjects
TAKOTSUBO cardiomyopathy ,CHILD patients ,CARDIOGENIC shock ,AGE groups ,VENTRICULAR ejection fraction - Abstract
Takotsubo syndrome (TTS) in the pediatric population is an infrequent but relevant cause of morbidity and mortality, with limited studies addressing its clinical course and prognosis. We aimed to analyze the clinical features and prognosis of pediatric TTS in a nation-wide multicenter registry and considering the published literature. We included a total of 54 patients from 4 different hospitals in Spain, as well as pediatric TTS patients from the published literature. Comparisons between groups were performed in order to assess for statistically and clinically relevant prognostic differences between pediatric and adult population features. Patients with pediatric TTS are more commonly male and exhibit a higher prevalence of physical triggers. The left ventricular ejection fraction (LVEF) was significantly lower in the pediatric population (30.5 + 10.4 vs 36.9 + 16.9, p < 0.05), resulting in more than fivefold rates of cardiogenic shock on admission compared to the general adult TTS population (Killip IV 74.1% vs 10.5%, p < 0.001) with similar rates of death and recurrence between groups. TTS in the pediatric population presents a distinctive clinical profile, with higher prevalence of atypical symptoms and physical triggers, as well as higher rates of cardiogenic shock on admission and similar mortality and recurrence rates than those of the adult population. This study provides valuable insights into understanding pediatric TTS and underscores the necessity for further research in this age group. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Post-COVID-19 Cardiac Complications: Understanding the Immune Niche Alterations in the Heart.
- Author
-
Khan, Mohammad Nadeem
- Subjects
HEART disease risk factors ,HEART diseases ,CARDIOMYOPATHIES ,POST-acute COVID-19 syndrome ,PERICARDITIS ,HEART failure ,TAKOTSUBO cardiomyopathy ,ARRHYTHMIA ,ACUTE coronary syndrome ,AUTOIMMUNE diseases ,INFLAMMATION ,CYTOKINES ,COVID-19 ,THROMBOSIS - Abstract
The COVID-19 pandemic has not only affected the respiratory system but has also led to significant cardiac complications, including myocarditis, pericarditis, arrhythmias, and thrombotic events. This document reviews the immune niche alterations in the heart following COVID-19 outbreaks, focusing on the direct viral effects, immune response, observed cardiac complications, long-term implications, therapeutic approaches, and future directions. SARS-CoV-2 infiltrates cardiac cells via ACE2 receptors, leading to viral myocarditis and myocardial injury. The immune response triggered by the virus contributes to myocardial inflammation and tissue damage. Cardiac complications observed in COVID-19 patients include myocarditis, pericarditis, arrhythmias, and thrombotic events. Long-term implications of COVID-19 on cardiac health include persistent inflammation, myocardial fibrosis, autoimmune responses, postural orthostatic tachycardia syndrome (POTS), and long-term arrhythmias, among others. Management of these complications requires a multidisciplinary approach, including anti-inflammatory treatments, antiviral therapies, immunomodulatory agents, cardiac-specific therapies, and longterm monitoring and rehabilitation programs. Future research aims to identify biomarkers for early detection of cardiac involvement, develop personalized treatment strategies, and explore innovative therapies such as regenerative medicine approaches. Understanding the immune niche alterations in the heart post-COVID-19 is crucial for improving outcomes and mitigating the burden of cardiac complications in affected individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2024
43. S100A9 as a Key Myocardial Injury Factor Interacting with ATP5 Exacerbates Mitochondrial Dysfunction and Oxidative Stress in Sepsis-Induced Cardiomyopathy.
- Author
-
Pei, Hui, Qu, Jie, Chen, Jianming, Zhao, Guangju, and Lu, ZhongQiu
- Subjects
TAKOTSUBO cardiomyopathy ,TRANSMISSION electron microscopy ,POLYMERASE chain reaction ,MEMBRANE potential ,MITOCHONDRIAL membranes - Abstract
Purpose: Sepsis-induced cardiomyopathy (SICM) is a prevalent cardiac dysfunction caused by sepsis. Mitochondrial dysfunction is a crucial pathogenic factor associated with adverse cardiovascular adverse events; however, research on SICM remains insufficient. Methods: To investigate the factors contributing to the pathological progression of SICM, we performed a comprehensive analysis of transcriptomic data from the GEO database using bioinformatics and machine learning techniques. CRISPR-Cas9 S100A9 knockout mice and primary cardiomyocytes were exposed to lipopolysaccharide to simulate SICM. Transcriptome analysis and mass spectrometry of primary cardiomyocytes were used to determine the potential pathogenic mechanisms of S100A9. The mitochondrial ultrastructure and mitochondrial membrane potential (MMP) were detected using transmission electron microscopy and flow cytometry, respectively. Pink1/Parkin and Drp1 proteins were detected using Western blotting to evaluate mitochondrial autophagy and division. The mtDNA and mRNA levels of mitochondrial transcription factors and synthases were evaluated using real-time polymerase chain reaction. Results: Bioinformatics analysis identified 12 common differentially expressed genes, including SERPINA3N, LCN2, MS4A6D, LRG1, OSMR, SOCS3, FCGR2b, S100A9, S100A8, CASP4, ABCA8A, and NFKBIZ. Significant S100A9 upregulation was closely associated with myocardial injury exacerbation and cardiac function deterioration. GSEA revealed that myocardial contractile function, oxidative stress, and mitochondrial function were significantly affected by S100A9. Knocking out S100A9 alleviates the inflammatory response and mitochondrial dysfunction. The interaction of S100A9 with ATP5 enhanced mitochondrial division and autophagy, inhibited MMP and ATP synthesis, and induced oxidative stress, which are related to the Nlrp3-Nfkb-Caspase1 and Drp1-Pink1-Parkin signaling pathways. The expression of mitochondrial transcription factors (TFAM and TFBM) and ATP synthetases (ATP6 and ATP8, as well as COX1, COX2, and COX3) was further suppressed by S100A9 in SICM. Targeted S100A9 inhibition by paquinimod partially reversed myocardial mitochondrial dysfunction and oxidative stress. Conclusion: The interaction of S100A9 with ATP5 exacerbates myocardial damage in sepsis by inducing mitochondrial dysfunction and oxidative stress. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
44. Incidence of Takotsubo cardiomyopathy in patients with acute coronary syndrome: a single center retrospective analysis
- Author
-
Tibor Poruban, Martin Studencan, Peter Kirsch, and Robert Novotny
- Subjects
Acute coronary syndrome ,Takotsubo cardiomyopathy ,Incidence ,Stress ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Background Takotsubo cardiomyopathy (TTC) is an acute and usually reversible condition that often mimics the course of acute coronary syndrome (ACS), making it particularly challenging to differentiate, especially in the initial phases. In this study, we retrospectively analyzed the incidence, clinical course, examination results, and in-hospital mortality of TTC in patients with ACS hospitalized at our cardiology center from January 2018 to October 2023. Results During the study period, a total of 3835 selective coronary angiograms were urgently performed at our facility, with a diagnosis of TTC established in 52 (1.35%) patients, the majority of whom were females—48 (93%), with an average age of 64.2 ± 10.2 years. Stress-induced mechanisms were identified in 36 (69%) patients. The most common symptom was chest pain (86.5%). Electrocardiographic changes primarily included ST-segment elevations (61.6%) and depressions (14%). The average left ventricular ejection fraction was 45.1 ± 8.3 (33–57%), typically with an echocardiographic pattern of apical ballooning dysfunction followed by midventricular dyskinesia. In-hospital mortality was zero. Conclusions TTC is a reversible condition with a low incidence of complications. Its occurrence in our patient cohort is lower compared to international registries. However, as demonstrated in this study, it is associated with significant in-hospital morbidity.
- Published
- 2024
- Full Text
- View/download PDF
45. Perioperative management of Takotsubo cardiomyopathy: an overview
- Author
-
Marta Pillitteri, Etrusca Brogi, Chiara Piagnani, Giuseppe Bozzetti, and Francesco Forfori
- Subjects
Takotsubo cardiomyopathy ,Takotsubo syndrome ,Broken heart syndrome ,Left ventricular apical ballooning syndrome ,Stress cardiomyopathy ,Perioperative period ,Anesthesiology ,RD78.3-87.3 ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
Abstract Resembling the morphology of Japanese polyp vessels, the classic form of Takotsubo cardiomyopathy is characterized by the presence of systolic dysfunction of the mid-apical portion of the left ventricle associated with basal hyperkinesia. It is believed that this may be due to a higher density of β-adrenergic receptors in the context of the apical myocardium, which could explain the greater sensitivity of the apex to fluctuations in catecholamine levels. The syndrome is precipitated by significant emotional stress or acute severe pathologies, and it is increasingly diagnosed during the perioperative period. Indeed, surgery, induction of general anaesthesia and critical illness represent potential harmful trigger of stress cardiomyopathy. No universally accepted guidelines are currently available, and, generally, the treatment of TTS relies on health care personal experience and/or local practice. In our daily practice, anaesthesiologists can be asked to manage patients with the diagnosis of new-onset Takotsubo before elective surgery or an emergent surgery in a patient with a concomitant stress cardiomyopathy. Even more, stress cardiomyopathy can arise as a complication during the operation. In this paper, we aim to provide an overview of Takotsubo syndrome and to discuss how to manage Takotsubo during surgery and in anaesthesiologic special settings.
- Published
- 2024
- Full Text
- View/download PDF
46. Takotsubo cardiomyopathy in a 7-month-old infant with familial hemophagocytic lymphohistiocytosis: A case report
- Author
-
Payal Gupta, S. Sumant Patil, and Usha Pillay
- Subjects
cardiomyopathy ,hemophagocytic lymphohistiocytosis ,infant ,takotsubo cardiomyopathy ,Pediatrics ,RJ1-570 - Abstract
Takotsubo cardiomyopathy constitutes an acute cardiac condition that mimics acute myocardial infarction in the absence of coronary artery disease. We present a case of a 7-month-old girl, who was admitted in the pediatric intensive care unit (PICU) at a tertiary care hospital for clinical deterioration with underlying familial hemophagocytic lymphohistiocytosis. During the PICU stay, on echocardiography, the patient had severe cardiac contractility compromise with a characteristic pattern of regional wall motion abnormalities of the left ventricle. This, in combination with elevated cardiac enzymes, led to the diagnosis of takotsubo cardiomyopathy.
- Published
- 2024
- Full Text
- View/download PDF
47. Life-style Interventions for Modulating the Brain Phenotype of Takotsubo Cardiomyopathy (BREAKOUT)
- Author
-
NHS Grampian
- Published
- 2023
48. Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy (GENETIC)
- Published
- 2023
49. Physical Exercise and Mental Wellbeing Rehabilitation for Acute Stress-induced Takotsubo Cardiomyopathy: The PLEASE Study (PLEASE)
- Author
-
British Heart Foundation
- Published
- 2023
50. Establishing the Incidence of Tako-tsubo Cardiomyopathy in Scotland (STARR)
- Author
-
NHS Tayside, NHS Lothian, NHS Highlands, NHS Ayrshire and Arran, Golden Jubilee National Hospital, NHS Greater Glasgow and Clyde, and NHS Lanarkshire
- Published
- 2023
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.